Michael E. Tarnoff
CIK: 0001603289
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Tarnoff Michael E
Tarnoff Michael E (SEC CIK 0001603289) files insider reports with the SEC as Director of ANGIODYNAMICS INC (ANGO) and Director of AVITA Medical, Inc. (RCEL).
Signal8 holds 4 ownership filings by Tarnoff Michael E (1 Form 3, 3 Form 4), filed between Jul 18, 2025 and Jul 22, 2026. Those filings report 4 transactions, from Jul 16, 2025 to Jul 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Tarnoff Michael E's filings is in LATHAM, NY.
Recent filings by Tarnoff Michael E
Other insiders filing for ANGIODYNAMICS INC (ANGO)
- Trowbridge Stephen A, EVP and CFO
- Piccinini Laura, SVP International
- Nighan Warren JR, SVP Quality and Regulatory
- Clemmer James C, President and CEO
- Campbell Chad Thomas, SVP/GM, Vascular Access
- REED JAN STERN, Director